2014
DOI: 10.2485/jhtb.23.21
|View full text |Cite
|
Sign up to set email alerts
|

Vascularization of Novel Porcine Acellular Dermal Matrix

Abstract: The aims of this study were to observe the growth of vascular endothelial cells (VECs) and the vascularization of novel porcine acellular dermal matrix (PADM), and to investigate the methods for modifying heterologous dermal substitutes in order to improve their compatibility. Twenty-four Wistar rats were divided into a PADM group and a HADM group, which were transplanted with PADM and HADM, respectively. At the 3rd day, and at the 1st, 2nd, and 4th week after the operation, the dermal substitute was removed, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Hence, PADM is often chemical or physical modified to adjust its physicochemical properties, especially the enzymatic degradation rate to meet the clinical requirements, with the methods of UV‐light irradiation, dehydrathermal treatment (DHT), and synthetic crosslinking reagents (carbodiimide (EDC), glutaraldehyde (GA), and polyepoxy compound) . However, the UV‐light irradiation treatment confines to the surface modification of PADM, the treatment by DHT makes little contribution to the physicochemical property of PADM and the cytotoxic nature of synthetic crosslinking agents i.e., EDC, GA, and polyepoxy compound reflected in the process of modifying PADM may prohibit their utilization in the field of tissue engineering . To overcome the aforementioned cytotoxic effect of synthetic crosslinking agents and the low efficacy of physical crosslinking treatments, a natural derived crosslinker, alginate dialdehyde (ADA) was developed in our previous work …”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…Hence, PADM is often chemical or physical modified to adjust its physicochemical properties, especially the enzymatic degradation rate to meet the clinical requirements, with the methods of UV‐light irradiation, dehydrathermal treatment (DHT), and synthetic crosslinking reagents (carbodiimide (EDC), glutaraldehyde (GA), and polyepoxy compound) . However, the UV‐light irradiation treatment confines to the surface modification of PADM, the treatment by DHT makes little contribution to the physicochemical property of PADM and the cytotoxic nature of synthetic crosslinking agents i.e., EDC, GA, and polyepoxy compound reflected in the process of modifying PADM may prohibit their utilization in the field of tissue engineering . To overcome the aforementioned cytotoxic effect of synthetic crosslinking agents and the low efficacy of physical crosslinking treatments, a natural derived crosslinker, alginate dialdehyde (ADA) was developed in our previous work …”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] As a biological scaffold, PADM is obviously biocompatible and not only provide mechanical support serving as an ideal threedimensional (3D) architecture for host cells to grow and metabolize, but also facilitate cell-scaffold interactions, which actively influence cellular responses, for instance, cell proliferation, and differentiation. 4,5 Accordingly, PADM has been extensively applied as substrates for skin repairing, as implants for breast shaping, and as scaffolds for dura matter, bone, and soft connective tissue remodeling. 3,6 Despite many of the superiorities of PADM as sketched above, the relatively weak enzymeresistance property of PADM may limit its use as biological scaffolds which need to be faced up to.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations